BioScrip (BIOS) stock price, revenue, and financials

BioScrip market cap is $282 m, and annual revenue was $708.90 m in FY 2018

$282 M

BIOS Mkt cap, 10-Jun-2019

$191.5 M

BioScrip Revenue Q2, 2019
BioScrip Gross profit (Q2, 2019)64.7 M
BioScrip Gross profit margin (Q2, 2019), %33.8%
BioScrip Net income (Q2, 2019)-15.7 M
BioScrip EBIT (Q2, 2019)6.9 M
BioScrip Cash, 30-Jun-201914.4 M
BioScrip EV792.9 M

BioScrip Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

842.2m984.1m982.2m935.6m817.2m708.9m

Revenue growth, %

17%0%(5%)

Cost of goods sold

721.3m670.0m547.9m465.9m

Gross profit

260.9m265.6m269.2m243.0m

Gross profit Margin, %

27%28%33%34%

General and administrative expense

42.5m39.2m39.6m47.3m

Operating expense total

42.5m39.2m39.6m232.1m

EBIT

(7.0m)(91.1m)(287.6m)10.9m

EBIT margin, %

(1%)(9%)(29%)2%

Interest expense

37.3m38.2m52.1m57.4m

Income tax expense

(21.5m)2.0m4.1m(568.0k)

Net Income

(69.7m)(147.5m)(299.7m)(41.5m)(64.2m)(51.7m)

BioScrip Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

15.6m9.6m39.5m14.5m

Accounts Receivable

114.9m

Inventories

43.0m36.2m38.0m26.7m

Current Assets

187.0m176.1m187.7m174.7m

PP&E

31.9m32.5m27.0m28.8m

Goodwill

308.7m365.9m367.2m367.2m

Total Assets

546.5m607.7m603.1m583.9m

Accounts Payable

65.1m59.1m66.0m67.0m

Short-term debt

27.7m18.5m1.7m3.2m

Current Liabilities

156.0m130.4m105.1m107.3m

Long-term debt

406.3m433.4m478.9m501.5m

Total Debt

434.0m451.9m480.6m504.7m

Total Liabilities

564.5m567.3m605.8m634.7m

Additional Paid-in Capital

531.8m611.8m624.8m618.1m

Retained Earnings

(601.9m)(643.4m)(709.5m)(761.2m)

Total Equity

(80.9m)(84.8m)(144.0m)

Debt to Equity Ratio

-5.4 x-5.7 x

Debt to Assets Ratio

0.8 x0.7 x0.8 x

Financial Leverage

-6.8 x-7.1 x-4.1 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

9.3m1.5m23.2m1.2m29.4m8.1m51.4m2.8m16.0m40.5m33.0m30.4m20.8m18.9m5.7m14.4m

Accounts Receivable

120.8m118.1m

Inventories

30.3m34.8m34.5m33.8m41.9m42.4m26.9m29.1m32.4m33.4m30.5m28.8m27.8m41.5m25.3m23.1m27.5m27.8m

Current Assets

222.1m251.3m238.8m215.6m212.4m185.4m199.4m158.8m199.0m159.4m176.0m190.5m170.2m176.0m156.6m171.9m171.1m177.6m

PP&E

41.1m40.0m39.9m40.0m35.9m34.9m34.1m30.5m30.8m33.7m30.4m30.1m28.7m25.0m

Goodwill

605.7m571.8m572.9m573.3m573.3m335.3m308.7m308.7m308.7m373.1m365.9m365.9m367.2m367.2m367.2m367.2m367.2m367.2m

Total Assets

926.3m900.1m883.8m858.8m845.4m577.1m562.7m503.5m543.2m595.4m602.4m613.4m590.2m586.9m566.1m579.2m597.2m600.6m

Accounts Payable

50.3m68.3m69.7m74.8m91.1m77.1m53.4m53.1m48.9m45.7m47.4m46.4m42.7m68.8m49.3m63.9m77.5m73.4m

Short-term debt

35.3m431.0k431.0k4.9m325.0k238.0k39.6m32.2m9.4m48.2m22.4m1.7m1.8m1.1m957.0k2.1m4.5m5.9m

Current Liabilities

133.5m127.6m125.6m135.5m145.2m134.0m146.8m135.7m101.7m140.9m121.7m102.9m89.0m103.7m82.2m96.0m115.6m116.2m

Long-term debt

380.3m418.2m418.3m418.4m418.5m418.6m409.3m391.7m390.1m388.1m450.1m475.7m476.8m480.4m492.3m496.8m506.7m519.4m

Total Debt

415.6m418.7m418.7m423.3m418.8m418.9m448.9m423.9m399.5m436.2m472.5m477.4m478.6m481.4m493.3m498.8m511.3m525.3m

Total Liabilities

556.0m567.4m568.8m580.3m587.2m562.5m563.0m529.9m494.0m550.1m575.9m600.0m588.8m602.4m595.6m615.5m657.3m675.8m

Additional Paid-in Capital

516.8m523.0m525.2m527.4m536.8m534.1m533.1m530.7m612.6m606.7m615.0m628.5m626.6m622.7m621.0m620.0m616.5m614.3m

Retained Earnings

(136.2m)(180.1m)(199.9m)(238.6m)(321.9m)(566.7m)(583.5m)(611.4m)(619.7m)(630.9m)(662.8m)(692.0m)(704.6m)(722.5m)(737.7m)(745.8m)(771.5m)(787.2m)

Total Equity

370.3m332.7m(43.3m)(61.1m)(91.5m)(18.1m)(24.3m)(47.9m)(63.5m)(78.0m)(100.2m)(117.0m)(126.7m)(156.3m)(174.5m)

Debt to Equity Ratio

1.1 x1.3 x-9.7 x-7.3 x-4.6 x-22.1 x-18 x-9.9 x-7.5 x-6.1 x-4.8 x-4.2 x-3.9 x

Debt to Assets Ratio

0.4 x0.5 x0.5 x0.5 x0.7 x0.8 x0.8 x0.7 x0.7 x0.8 x0.8 x0.8 x0.8 x0.9 x0.9 x

Financial Leverage

2.5 x2.7 x-13.3 x-9.2 x-5.5 x-30.1 x-24.5 x-12.6 x-9.7 x-7.6 x-5.9 x-4.8 x-4.6 x-3.8 x-3.4 x

BioScrip Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(299.7m)(41.5m)(64.2m)(51.7m)

Depreciation and Amortization

22.7m21.6m27.7m23.6m

Accounts Receivable

(29.3m)

Inventories

(5.8m)10.0m(2.5m)11.4m

Accounts Payable

(24.1m)(20.5m)689.0k1.1m

Cash From Operating Activities

(61.1m)(261.0k)(64.7m)(42.8m)(763.0k)(20.1m)

Purchases of PP&E

(11.5m)(9.6m)(8.7m)(13.9m)

Cash From Investing Activities

13.0m(73.0m)(13.6m)(13.5m)

Cash From Financing Activities

66.6m109.7m44.3m8.1m

Interest Paid

34.3m34.7m45.4m41.5m

BioScrip Ratios

USDY, 2019

EV/EBIT

432.1 x

EV/CFO

-759.3 x

Financial Leverage

-3.4 x

BioScrip Employee Rating

2.7218 votes
Culture & Values
2.3
Work/Life Balance
2.5
Senior Management
2.1
Salary & Benefits
2.5
Career Opportunities
2.4
Source